Kaposi's sarcoma-associated herpesvirus (KSHV) is a human gammaherpesvirus casually linked to Kaposi's sarcoma (KS), multicentric Castleman's disease (MCD), and primary effusion lymphoma (PEL). Previously, we showed that LANA encoded by KSHV upregulates expression of survivin, a member of the inhibitor of apoptosis (IAP) family. This leads to an increase in the rate of cell proliferation of KSHV-infected B cells. LANA is required for tethering of the KSHV episome to the host chromosomes and efficiently segregates the viral genomes into dividing tumor cells. Here we show that LANA interacts with Aurora kinase B (AK-B) and induces phosphorylation of survivin at residue T34. Phosphorylation of survivin specifically on residue T34 enhances the activity of p300 and inhibits the activity of histone deacetylase 1 (HDAC-1), which then leads to an increase in acetylation of histone H3 on the viral genome. Phosphorylation of survivin specifically on residue T34 upregulates the activities of histone acetyltransferases and deacetylases, which then leads to an increase in viral copy number in KSHV-infected B cells. This results in a boost of KSHV replication in latently infected B-lymphoma cells. The studies showed that LANA can also function to regulate viral replication prior to mitosis of the latently infected cells, suggesting that LANA possesses a novel role in regulating KSHV replication in infected B cells.
T
he chromosomal passenger complex (CPC), composed of Aurora kinase B (AK-B) and its regulatory subunits INCENP, survivin, and borealin, modulates multiple events during mitosis (1) . AK-B plays a critical role during cytokinesis and is required for histone H3 phosphorylation, chromosome biorientation, the spindle assembly checkpoint, and cytokinesis (2, 3) . Inhibition of AK-B activity with small molecules leads to cytokinesis failure and abnormal exit from mitosis, resulting in endoreduplication, polyploidy cells, and ultimately apoptosis (6, 7) . Survivin is a critical member of the CPC, which recognizes phosphorylated histone H3 threonine 3 and activates AK-B (2). Inhibition of survivin phosphorylation damages chromosome biorientation and centromere CPC targeting (3) . Survivin has also been implicated in the inhibition of caspase activation, which leads to negative regulation of apoptosis and induction of cell proliferation. Our studies have also shown that survivin contributes to virus-induced cell proliferation and blocks apoptosis (8, 9) . Recent studies have shown that increased survivin expression was required for varicella-zoster virus (VZV) replication and spread (4) .
Studies have shown that Polo-like kinase 1 is linked to hepatitis C virus (HCV) replication by hyperphosphorylating NS5A protein (5) and that herpes simplex virus 1 induces nuclear accumulation of hyperphosphorylated tau in neuronal cells (6) . Increments of lamin A/C phosphorylation were seen in African swine fever virus (ASFV)-infected cells as early as 4 h postinfection (7) . These studies suggest that phosphorylation is a critical strategy for usurping signaling mechanisms for successful virus infection and replication. Our data now showed that knockdown of survivin in Kaposi's sarcoma-associated herpesvirus (KSHV)-infected B cells results in dramatically decreased copies of the KSHV genome. Therefore, we postulated that phosphorylated survivin is likely to be critical for KSHV genome replication.
KSHV is tightly associated with primary effusion lymphoma (PEL), multicentric Castleman's disease (MCD), and Kaposi's sarcoma (KS) (10) (11) (12) . The virus utilizes a complicated series of molecular strategies to prevent cell apoptosis, regulate cell proliferation, and induce cell transformation (10) (11) (12) (13) . LANA, encoded by open reading frame 73 (ORF73), is the major latent protein expressed in all forms of KSHV-associated malignancies. LANA is a multifunctional protein which has the ability to (i) associate with cellular chromatin to maintain the viral episome (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) , (ii) activate or repress transcription (9, (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) , (iii) subvert tumor suppressors (38, 40, (43) (44) (45) , (iv) stimulate cellular transformation (16, 34, (46) (47) (48) (49) (50) (51) , and (v) block apoptosis (9, 49, (52) (53) (54) (55) (56) (57) (58) (59) (60) . Our previous study has shown that LANA can upregulate survivin expression and promote cell proliferation (9) . However, the mechanism was somewhat elusive. In this study, we wanted to test our hypothesis that KSHV-encoded LANA can interact with AK-B and lead to enhanced phosphorylation of survivin T34 and that the interaction upregulates histone H3 acetylation and enhances KSHV replication in KSHV-infected B-lymphoma cells.
MATERIALS AND METHODS
Ethics statement. De-identified human peripheral blood mononuclear cells (PBMCs) were obtained from the University of Pennsylvania CFAR Immunology Core. Each donor gave written, informed consent according to the principles of Declaration of Helsinki protocols.
Plasmids, cells lines, and antibodies. BC3 and JSC-1 were cultured in RPMI 1640 (Life Technologies, Carlsbad, CA) with 7% bovine growth serum (Thermo Fisher Scientific, Waltham, MA). LANA antibody was purified from mouse ascites, which were injected with an anti-LANA antibody-producing hybridoma (a gift from Ke Lan, Institute Pasteur of Shanghai, Shanghai, China). The anti-AK-B, antisurvivin, anti-acetylated histone H3 (anti-H3Ac), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were obtained from Santa Cruz (Santa Cruz, CA), Cell Signaling (Danvers, MA), Millipore (Billerica, MA), and Novus (Littleton, CO), respectively.
Immunofluorescence. Immunofluorescence assays were performed as previously described (61, 62) . Briefly, BC3 and JSC-1 cells were fixed and incubated with primary antibodies with mouse anti-LANA and rabbit anti-AK-B or antisurvivin. Alexa Fluor anti-mouse 488 and anti-rabbit 594 were used as secondary antibodies, and 4=,6-diamidino-2-phenylindole (DAPI) was used for staining the nuclei.
Immuno-FISH. Immunofluorescence and fluorescence in situ hybridization (immuno-FISH) assays were performed as previously described (27) . Briefly, cells infected with wild-type (wt) KSHV were harvested at 1 day postinfection (dpi), 2 dpi, 4 dpi, and 7 dpi. Cells were fixed in 4% paraformaldehyde at room temperature for 30 min and permeabilized with 0.5% Triton X-100. Subsequently, cells were treated with 100 g/ml of RNase A in 2ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate). The slides were overlaid with in situ hybridization solution containing 20 ng of KSHV TR probe labeled with biotin using the BioNick labeling system (Invitrogen, Inc.) according to the manufacturer's suggestions. After denaturation of DNA at 93°C for 5 min, slides were incubated overnight at 37°C, washed in 0.2ϫ standard saline citrate for 30 min at 45°C, and blocked in TNB (0.1 M Tris-HCl [pH 7.5], 0.15 M NaCl, 0.5% milk powder) at room temperature for 30 min. Survivin-specific or H3Ac-specific polyclonal antibody was added to the slides and the slides were incubated overnight at 4°C, followed by incubation with an Alexa Fluor 594 donkey anti-rabbit IgG and an Alexa Fluor 680-streptavidin conjugate. Slides were washed and counterstained with DAPI, followed by mounting with antifade and visualizing by a Fluoview FV300 confocal microscope (Olympus Inc., Melville, NY).
RNA interference (RNAi). The short hairpin RNA (shRNA)-control, shRNA-survivin, and shRNA-LANA were described previously (9, 27) . The shRNA against AK-B (target sequence, CGAGACCTATCGCCGC ATC) (63, 64) was constructed as described previously (9) .
Centrifugal elutriation and cell cycle analysis. Centrifugal elutriation was performed as described previously (65) . Briefly, BC3 and JSC-1 cells grown in RPMI 1640 at 5 ϫ 10 5 cells/ml were separated into different cell cycle phases, with flow rates of 12, 14, 16, 18, 20, 24, 29 , and 36 ml/min, by a modified Beckman JE 5.0 rotor (Beckman Coulter Inc., Brea, CA). The relative DNA contents of the different fractions were determined by flow cytometry (Becton, Dickinson Inc., Franklin Lakes, NJ) by the fluorescence intensity of propidium iodide-stained cells. The fractions of G 1 , S, G 2 , and M were assigned for Western blot analysis and virus quantification.
Virus quantification. Virus quantification assays were implemented as described previously (62) . Briefly, BC3, BC3-Sh-C, BC3-Sh-LANA, BC3-Sh-Sur, JSC-1, JSC-Sh-C, JSC-Sh-LANA, and JSC-Sh-Sur cells were harvested and washed 3 times with 1ϫ phosphate-buffered saline (PBS) and then incubated in lysis buffer (20 mM Tris-HCl at pH 8, 10 mM EDTA, 100 mM NaCl, 0.5% SDS) at room temperature for 10 min. Proteinase K at 0.5 mg/ml was added and cells were incubated at 37°C overnight, with subsequent extraction with phenol-chloroform-isoamyl alcohol. Viral DNA was precipitated and resuspended in water, which was used in the subsequent TaqMan and SYBR green assays for virus copies by primers sets for ORF49 (5=-ACTGAAAGGAGGGAGCACAC-3= and 5=-GCTGCATAGGTTTTGAGAGA-3=) and ORF K3 (5=-GGCCGTGTTTC TAGAGATAGTG-3= and 5=-GGGACCCCGGTTGCCTGGAC-3=).
Primary infection. The primary infection was performed as described previously (61, 62) . Briefly, 3.0 ϫ 10 6 Bac36-293 cells were seeded on T175 flask 24 h prior to induction. Butyric acid at a final concentration of 3 mM and 2-O-tetradecanoylphorbol-13-acetate (TPA; Sigma) at 20 ng/ml were used for lytic induction. Cell suspensions were centrifuged at 3,000 rpm for 20 min, and the supernatant was filtered through a 0.45-m cellulose acetate filter. The viral particles were concentrated by ultracentrifugation at 70,000 ϫ g at 4°C and stored at Ϫ80°C. A total of 1 ϫ 10 6 PBMCs were infected by incubation with a virus suspension (ϳ1 ϫ 10 10 virions) in 1 ml of RPMI 1640 (10% fetal bovine serum [FBS] ) medium in the presence of Polybrene at a final concentration of 5 g/ml and incubated for 4 h in 37°C. Cells were centrifuged for 5 min at 1,500 rpm, the supernatant was discarded, and pelleted cells were washed with fresh RPMI 1640 twice and resuspended in fresh RPMI 1640 (10% FBS). Infected cells were harvested at different days postinfection. Immuno-FISH assays were performed as described above.
RNA isolation and qPCR. RNA samples from BC3, BC3-Sh-C, BC3-Sh-LANA, BC3-Sh-AK-B, BC3-Sh-Sur, JSC-1, JSC-Sh-C, JSC-Sh-LANA, JSC-Sh-AK-B, and JSC-Sh-Sur cells were extracted by using TRIzol (Invitrogen, Inc., Carlsbad, CA) according to the manufacturer's instructions. The cDNAs were prepared by using the High-Capacity RNA-tocDNA kit (Applied Biosystems Inc., Foster City, CA). Real-time quantitative PCR (qPCR) was performed on a StepOnePlus Real-Time PCR system (Applied Biosystems Inc., Carlsbad, CA) as described previously. The threshold cycle (C T ) value was calculated from amplification plots, and gene expression was normalized using the C T of the endogenous control GAPDH. The primer sets were used in these experiments as listed in Table 1 . Histone acetyltransferase CAGCTGCAGAAGCTCAACAA GGTTGCAATCTCGGAAGTG Kinase assays. The constructs for glutathione S-transferase (GST) fusion proteins (GST-survivin and GST-survivin-T34A) were gifts from Dario C. Altieri (The Wistar Institute, Philadelphia, PA). The GST constructs were transformed into Escherichia coli BL21 cells, and the GST fusion proteins were purified as described previously (66, 67) . 
RESULTS
LANA associates with AK-B in cellular complex. LANA is one of the major latent proteins expressed in all forms of KSHV-associated malignancies. Our previous studies showed that LANA interacted with Bub1 and CENP-F, which contributed to KSHV genome maintenance and segregation (27) . Recently, we showed that LANA upregulated Aurora A transcription and promoted p53 phosphorylation and ubiquitylation (29) . These studies further indicated that KSHV-encoded LANA may be involved in cell mitosis. In this study, we investigated the association of LANA and AK-B in human cells. We carried out coimmunoprecipitation (co-IP) assays by expressing LANA with AK-B in 293 cells to detect the associated complex. The results showed that LANA strongly immunoprecipitated with AK-B (Fig. 1A) . We further performed co-IP using the KSHV-infected B-lymphoma cell lines BC3 and JSC-1. The results convincingly showed that the endogenous LANA is in a complex with AK-B in KSHV-infected cells compared to the KSHV-negative cell line BJAB (Fig. 1B) . AK-B is well known for having a critical role in progression of mitosis. Therefore, we postulated that the interaction between LANA and AK-B is likely to be different in each phase of the cell cycle. Therefore, immunofluorescence assays were performed for detecting LANA and AK-B in cells at different stages of the cell cycle. Interestingly, the results showed that LANA preferentially interacted with AK-B in interphase in KSHV latently infected cells (Fig. 1C  and D ). In conclusion, the immune localization data clearly indicated that KSHV LANA can associate with AK-B during interphase.
Knockdown of survivin significantly decreases KSHV genome copies in KSHV-infected B-lymphoma cells. Survivin, an inhibitor of apoptosis, has been previously shown to contribute to proliferation of KSHV-infected cells (9) . A recent study has showed that increased survivin expression was required for replication of a number of viruses (4) . Therefore, we wanted to determine if survivin may affect KSHV genome copies in latently infected cells. We compared the viral genome copies in AK-B (Sh-AK-B), LANA (Sh-LANA), and survivin (Sh-Sur) knockdown cell lines by RT-qPCR analysis. The results showed that Uninfected and infected PBMCs at 1 dpi, 2 dpi, 4 dpi, and 7 dpi were incubated with biotin-labeled KSHV TR probes and rabbit antisurvivin antibody. The GFP signal suggests the presence of viral genome in the PBMCs. The survivin and TR were quantified by counting the discrete foci in each cell. DIC, differential interference contrast. *, P Ͻ 0.05 by Student's t test. Magnification, ϫ400.
survivin knockdown led to significant decreases, 90% in BC3 cells and 95% in JSC-1 cells, of viral episome copies, indicating that survivin has a role in the maintenance of KSHV viral copy number (Fig. 2B ). In addition, there were fewer KSHV episomal copies in the LANA and AK-B knockdown cell lines (Fig. 2B) , suggesting that LANA and AK-B might function as upstream regulators of survivin, important for KSHV replication.
Upregulation of survivin increases KSHV virus replication during KSHV infection. Our previous work showed that KSHV LANA upregulated survivin expression in KSHV-infected cells (9) . In this study, we further investigated the relationship between survivin and KSHV genome copies in latently infected cells. We performed immuno-FISH assays in BC3 and JSC-1 cells to detect viral episomes. As expected, KSHV episomes were significantly reduced in survivin knockdown BC3 and JSC-1 cells (Fig. 3A and  B) . Further, LANA knockdown cells showed a 3-to 4-fold decrease in viral genome copies, suggesting that LANA levels affect viral copies. Although AK-B showed a slightly higher survivin expression, its knockdown led to prominent decrease in viral episomal copies compared to controls (Fig. 3A and B) . In addition, we performed immuno-FISH assays on human PBMCs infected with purified KSHV virions at 1, 2, 4, and 7 days postinfection (dpi). As expected, survivin expression gradually increased in KSHV-infected PBMCs (Fig. 3C) , which is consistent with KSHV LANA expression in KSHV-infected PBMCs (61). These results further supported our hypothesis that LANA can upregulate survivin in KSHV-infected cells. Surprisingly, upregulation of survivin led to a remarkable increase of KSHV episomal copies during early infection (Fig. 3C) . These results strongly suggested that survivin may contribute to the increase of KSHV genome copies in KSHV-infected cells.
Acetylated histone H3 regulates KSHV viral replication in a survivin-dependent manner. Previous studies showed that histone hypoacetylation is associated with replication timing of chromatin (68) . Therefore, we investigated whether histone H3 acetylation and survivin have any effect on the KSHV genome copy number. We performed immuno-FISH assays by using the specific antibody against acetylated histone H3 and a labeled TR probe which targets the KSHV virus genomes in Sh-AK-B, Sh-LANA, and Sh-Sur cell lines generated with the KSHV-positive BC3 and JSC-1 parental cells. As expected, we showed that AK-B and LANA knockdown led to an approximately 62% to 76% de- crease in the number of TR foci (Fig. 4A) . Strikingly, there was an approximately 88% to 90% decrease in the focus number of TR signals in the Sh-Sur cell lines compared to controls (Fig. 4A) . In addition, TR signals were enhanced in an H3Ac-dependent manner. Therefore, we further investigated the protein expression in the Sh-AK-B, Sh-LANA, and Sh-Sur PEL cell lines by Western blotting. The results showed that acetylated histone H3 was decreased by about 40% and 70% in Sh-LANA and Sh-Sur cell lines, respectively (Fig. 4E) . These results suggested that LANA and survivin affected the level of histone H3 acetylation and further indicated that acetylated histone H3 is important for KSHV viral replication in a survivin-dependent manner.
Survivin upregulates KSHV replication in KSHV-infected Blymphoma cells. Our data showed that LANA preferentially interacts with AK-B during the interphase of the cell cycle. Further, KSHV genome copies were dependent on the expression of survivin and the modification of histone acetylation. Previous studies have shown that survivin has different levels of expression during cell cycle phases in cancer cells (69, 70) . Therefore, we postulated that the expression of LANA, AK-B, and survivin may have an impact on KSHV genome copies in a cell cycle-dependent manner. In this study, we fractionated the KSHV latently infected BC3 and JSC-1 PEL cells from specific phases of the cell cycle using centrifugal elutriation. The purity of these fractions were confirmed by flow cytometric analysis (Fig. 5A) . The fractions of G 1 , S, and G 2 /M phases were then lysed, and the total cellular DNAs were extracted for RT-qPCR analysis using KSHV primer sets for ORF49 and ORF K3 to determine the genome copy number. Surprisingly, the KSHV viral copy number showed a peak at the G 1 phase (Fig. 5B) , suggesting that the KSHV genome copy number was amplified prior to mitosis during the G 1 phase. This was acceptable, as the observed interaction between LANA and AK-B predominantly occurred during the G 1 phase. These results suggest that survivin and histone H3 acetylation might affect G 1 phase of BC3 and JSC-1 cells. Therefore, we studied the profiles of these proteins during the cell cycle phases G 1 , S, and G 2 /M. Surprisingly, survivin had the highest expression in the G 1 fraction of BC3 as well as JSC-1 cells (Fig. 5C ). This high expression led to higher acetylated levels of histone H3 in the G 1 fractions of BC3 and JSC-1 cells (Fig. 5C ). In contrast, survivin reduction led to a noteworthy reduction in the levels of histone H3 acetylation (Fig. 5C) . These results showed that survivin is a key player in regulating KSHV episome copies at the G 1 cell cycle phase of KSHV-associated B-lymphoma cells. Survivin regulates the activities of histone acetyltransferases and deacetylases in KSHV-infected B-lymphoma cells. Histone acetylation is regulated by a balance of opposing histone deacetylase (HDAC) and histone acetyltransferase (HAT) activities (71) . HATs can transfer an acetyl group of acetyl coenzyme A (acetylCoA) to the lysine epsilon amino groups at the N-terminal tails of histones and play a crucial role in transcriptional regulation of genes (72) . HDACs include a large family of enzymes identified as key regulators of nucleosomal histone acetylation and are classified into four classes. However, only class I HDACs are ubiquitously present in various tissues (73) . Our data showed increased acetylated histone H3 in a survivin-dependent manner. This led to the hypothesis that survivin may upregulate HAT activities and/or downregulate HDAC activities. Therefore, we investigated the mRNA changes of HDACs (HDAC-1, -2, -3 and -8), and HATs (p300, CBP, PCAF, and Cited-2), in KSHV-infected BC3 and JSC-1 cells (Fig. 6) . The results showed that p300 was downregulated greater than 3-fold in BC3-Sh-Sur cells and approximately 5-fold in JSC-1-Sh-Sur cells compared to the controls, respectively (Fig. 6A) . Similarly, CBP and Cited-2 expression were repressed in the survivin knockdown cell lines but not at the level seen for p300 (Fig. 6B and D) . These results indicate that survivin depletion may result in reduced histone acetylation, as the major HATs were significantly reduced in the survivin knockdown BC3 and JSC-1 cells and so led to reduced hyperacetylation of histones (Fig. 6A to D) . Analysis of the deacetylases showed that HDAC-1 was upregulated about 2.5-and 4-fold in survivin knockdown BC3 and JSC-1 cells, respectively, suggesting a potential loss of histone acetylation in latently infected KSHV-positive cells (Fig. 6E) . Further analysis of HDAC-2, -3, and -8 did not show any dramatic upregulation as seen with HDAC-1 (compare Fig. 6E with 6F to H) . Furthermore, we performed Western blot analysis and showed that knockdown of survivin led to a significant decrease in p300 expression to undetectable levels and an increase in HDAC-1 expression of about 5-fold (Fig. 6I) . These data suggested that survivin can play a critical role in regulating the expression and activities of the histone acetyltransferase p300, as well as the deacetylase HDAC-1, in KSHV-infected B-lymphoma cells.
A complex of LANA and AK-B enhances phosphorylation of survivin. Phosphorylation of survivin at threonine 34 (T34) leads to its activation and stabilization (74) (75) (76) (77) . Previous studies have shown that AK-B phosphorylates survivin at threonine 117 within its carboxyl-terminal domain (78) . Therefore, we postulated that LANA can form a complex with AK-B to also enhance phosphorylation of survivin at T34, which may lead to enhanced survivin activity and stabilization. In this study, we performed a kinase assay using purified GST-survivin and immunoprecipitated AK-B and LANA complex. The result showed that the LANA and AK-B complex enhanced survivin phosphorylation about 6-fold compared to AK-B alone (Fig. 7A, lanes 4 to 6) . Significantly, survivin phosphorylation was reduced with LANA and AK-B complex if survivin was mutated at the T34 residue (Fig. 7A, lanes 7 to 9) . These results indicated that LANA can form a complex with AK-B and so enhance phosphorylation of survivin at T34. Immunoprecipitation of AK-B tagged with the myc epitope using anti-myc antibodies showed an association with Flag-tagged LANA as determined by Western blot analysis (Fig. 7B) .
Phosphorylation of survivin at T34 is important for regulating the activities of p300 and HDAC-1. The data above indicated that phosphorylation of survivin may play an important role in regulating the activities of p300 and HDAC-1. Therefore, we compared the mRNA expression of histone deacetylases and acetyltransferases in cells transfected with the survivin wt and T34A mutant. Survivin wt and T34A constructs were transfected into 293 cells. Total RNAs were extracted and converted to cDNAs at 48 h posttransfection. The mRNA levels of histone acetyltransferases and deacetylases were analyzed by RT-PCR. The results showed that HDAC-1 mRNA had an almost 2-fold increase with the T34A mutant compared to the value with wt survivin (Fig.  8A) . In contrast, p300 expression had an approximately 3.5-fold decrease with the T34A mutant, which indicated that phosphorylation of survivin was important to enhance p300 levels and its acetylating activity (Fig. 8B) . The phosphorylation of survivin at T34 was therefore important in regulating the levels of p300 and HDAC-1 and therefore is critical for accumulation of histone acetylation in latently infected KSHV-positive cells to enhance the replication of KSHV. Table 1 . (C) Hypothetical model showing that LANA and AK-B complex enhanced the phosphorylation of survivin and upregulates H3 acetylation, and this boosted KSHV replication in KSHV-infected B-lymphoma cells. KSHV infects cells through endocytosis and then delivers viral DNA to nucleus. During KSHV latent infection, KSHV-encoded LANA contributes the upregulation of survivin expression. At the same time, LANA interacts with AK-B and induces phosphorylation of survivin at residue T34. Phosphorylation of survivin specifically on residue T34 enhances the activity of p300 and inhibits the activity of HDAC-1, which then leads to an increase in acetylation of histone H3 on the viral genome. The phosphosurvivin now has enhanced activity and stability and so creates an environment for abundant acetylation of histone H3 on the viral genome important for KSHV latent infection.
DISCUSSION
Histone acetylation plays a major role in determining replication timing. Replication timing and firing efficiency at replication origins at distinct genomic regions are linked to higher histone acetylation levels (68) .
A number of studies have shown that phosphorylation of survivin can induce its activation and stabilization (74) (75) (76) (77) . Here, we proved that a complex of LANA and AK-B can enhance phosphorylation of survivin at T34. This further supports our hypothesis that the activity and stability of survivin are enhanced in KSHV latently infected cells. In addition, our previous study showed that KSHV LANA upregulated survivin expression in KSHV latently infected cells (9) . This can create an active and stable environment for regulating the activity of survivin. Furthermore, we pointed out that the G 1 phase is most favorable, because the host chromosome is decondensed and survivin expression was upregulated by KSHV-encoded LANA. Importantly, we also saw that survivin expression was higher in the G 1 cell cycle phase than in other phases in KSHVinfected B-lymphoma cells.
AK-B is a chromosomal passenger protein which maintains accurate chromosome segregation and progression of cells through mitosis (1). AK-B has been shown to interact with TACC1 (79), survivin (80, 81) , CDCA8 (82, 83) , and BARD1 (84) . Further, AK-B confers TRAIL-induced apoptosis via phosphorylation of survivin (85) . Recently, AK-B was shown to phosphorylate p53 and so initiated its degradation via MDM2-mediated ubiquitylation during interphase (86) . This study provided clues that AK-B may play a critical multifunctional role not only during the cell cycle but also in tumor growth. Here, we report that LANA can form a complex with AK-B during interphase and may enhance survivin phosphorylation, further supporting a role for AK-B as a multifunctional protein in KSHV-associated tumor growth.
Histone deacetylation leads to survivin gene silencing (87) . Therefore, KSHV-infected cells possessed a higher level of histone acetylation by upregulation of p300 and downregulation of HDAC-1. A recent report showed that transfection of an HDAC-1 expression vector into KSHV-infected cells resulted in the repression of ORF50 activity and that this repression was relieved by cotransfection of a CBP expression construct (88) . These studies suggested that KSHV can maintain its latency through regulation of the levels and activities of HATs and HDACs. Phosphorylation of the cellular protein nucleophosmin can control KSHV latency (89) . The results obtained in our study also showed that a LANA and AK-B complex can enhance phosphorylation of survivin during KSHV latent replication (89) . Therefore, the stabilization and activation of survivin can create an environment for hyperacetylation of histones in KSHV latently infected cells. Furthermore, we are intrigued by recent studies which showed that survivin expression can increase varicella-zoster virus (VZV) replication and pathogenesis (4), although this is likely to be linked to lytic replication.
Studies have shown that viral replication is linked to histone acetylation. For example, the acetylation status of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA)-bound H3 and H4 histones regulates HBV replication (90) . Human cytomegalovirus (HCMV) immediate early protein can contribute to viral replication by inhibiting histone deacetylation (91) . Histone hyperacetylation was associated with hepatitis delta virus (HDV) replication (92) . Also, inhibition of class I HDACs enhances histone acetylation at OriP and improves replication timing of latent EBV, and it has been shown to reduce Epstein-Barr virus (EBV) genome copy number (93) . Our studies further show that phosphorylation of survivin can create an environment of H3 histone hyperacetylation through upregulation of p300 expression and repression of HDAC-1 levels. This leads to the acceleration of KSHV latent replication.
During KSHV latent infection, KSHV-encoded LANA contributes to upregulation of survivin expression. At the same time, LANA interacts with AK-B, predominantly during the G 1 phase, and induces phosphorylation of survivin at residue T34. Phosphorylation of survivin specifically on residue T34 enhances the activity of p300 and inhibits the activity of HDAC-1, which then leads to an increase in acetylation of histone H3 on the viral genome. The phosphosurvivin now has enhanced activity and stability and so creates an environment for abundant acetylation of histone H3 on the viral genome important for KSHV latent infection (Fig. 8C) . This results in a boost of KSHV replication in latently infected B-lymphoma cells. These studies showed that LANA can also function to regulate viral replication prior to mitosis of the latently infected cells, suggesting that LANA possesses a novel role in regulating KSHV replication in infected B cells.
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